This major award is a great achievement for Allan and a boost for his team of scientists enabling the further understanding of molecular mechanisms in pulmonary arterial hypertension to aid the continued translation of novel therapies for patient benefit.
Continuing the Fight for Answers to PAH (Pulmonary Artery Hypertension)
Research Excellence Framework 2021 results
The results demonstrate our research and impact excellence across a broad range of disciplines and confirm that our research is having a significant positive impact on lives across the globe.